---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-259488"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2026-06-05T20:01:38+00:00"
generated_at: "2026-06-05T20:08:34.026335+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DBV Technologies grants CEO Daniel Tassé 4.06M PSUs tied to FDA approval of Viaskin Peanut

## Summary
- 4,060,000 PSUs awarded to CEO; vesting conditioned on FDA approval of Viaskin Peanut BLA.
- First FDA approval of VP (any age) triggers vesting of 2,900,000 PSUs; second approval for a different indication/age triggers 1,160,000 PSUs.
- Single BLA covering both age groups deems all performance conditions satisfied.
- Vested shares delivered in four equal installments starting July 1, 2028 through January 1, 2030.
- PSUs canceled if performance conditions not met by July 1, 2028; continued employment required.

## SEC filing metadata
- accession: 0001193125-26-259488
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2026-06-05T20:01:38+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312526259488/0001193125-26-259488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312526259488/d139789d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-259488
- JSON: https://secwatch.observer/filing/0001193125-26-259488.json
- Plain text: https://secwatch.observer/filing/0001193125-26-259488.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.